Cancer Biomarkers

Aims & Scope

Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion.

The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic, and genetic factors predisposing to the disease or indicating the occurrence of the disease.

Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation will be accepted.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.20

Journal Rank

Year	Value
2024	9908

Journal Citation Indicator

Year	Value
2024	741

SJR (SCImago Journal Rank)

Year	Value
2024	0.586

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	57

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Renal cell carcinoma

  Citation: 357

  Authors: Paul

• Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma

  Citation: 331

  Authors: Meilin, Gang, Xisong, Xuemei, Xiaomeng, Zhouhong, Juan, Jia, Lei, Wenxin

• Prediction of lung cancer using volatile biomarkers in breath1

  Citation: 251

  Authors: Michael, Nasser, John H.M., Robert B., Renee N., Joel, Robert, Roger A., Muhammad I., Harvey I., Asif, William N., Peter

• Tissue elasticity properties as biomarkers for prostate cancer

  Citation: 250

  Authors: Kenneth, Benjamin, Man, Priya, P. Anthony, Jean V., John, Deborah J., Kevin J.

• Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments

  Citation: 210

  Authors: Jennifer, Judith E., Ashkan

• Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma

  Citation: 178

  Authors: Xianguang, Yang, Qiqi, Xiaoyun, Weiru, Jiajie, Weijia, Liang, Xu

• Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging

  Citation: 171

  Authors: Yun, Jianghong

• The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines

  Citation: 134

  Authors: Yishan, Yanjie, Di, Kai, Ling, Yingchang, Cong, Xuanlang, Ping, Kejing

• Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer

  Citation: 129

  Authors: Kaijiong, Zhenglian, Yi, Li, Lichun, Lian, Jie, Xiaoyu, Jinbo

• African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: An epidemiologic review

  Citation: 124

  Authors: Dominik D., John, Timothy, Ellen, William, Upender

---